Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma
Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma
Letrozole vs observation for HR positive breast cancer
Comment: Nivolumab-based treatment halts melanoma progression
Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases
Preventive neck lymph node surgery improves early oral cancer survival
Preventive neck lymph node surgery improves early oral cancer survival
Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases
Improved care has extended lifespan of childhood cancer survivors since the 1970s
Phase III study finds initial nivolumab-based treatment halts melanoma progression
Improved care has extended lifespan of childhood cancer survivors since the 1970s
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis
Targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma